Metabolic Effects of Choline and Docosahexaenoic Acid Supplementation in Preterm Infants
NCT02509728 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2018-05-15
Summary
To explore the effects of enteral choline and DHA supplementation on plasma choline and DHA-PC concentrations and metabolism, this randomized controlled study will assign 40 preterm infants to 1 of 4 groups: standard care, choline supplementation, DHA supplementation, and choline and DHA supplementation.
After 7 days of supplementation, a single dose of stable isotope labelled choline will be administered and the kinetics of newly synthesized DHA-PC determined to assess plasma levels, uptake and distribution of choline and DHA.
This study is designed to inform larger studies evaluating this approach of enteral co-application of choline and DHA on clinical important outcomes.
Conditions
- Infant, Premature
Interventions
- DIETARY_SUPPLEMENT
-
choline supplementation
in addition to standard nutrition: enteral supplementation with 30mg/kg choline chloride for 10 days
- DIETARY_SUPPLEMENT
-
DHA supplementation
in addition to standard nutrition: enteral supplementation with 60mg/kg DHA for 10 days
- DIETARY_SUPPLEMENT
-
standard nutrition
standard nutrition
Sponsors & Collaborators
-
University Hospital Tuebingen
lead OTHER
Principal Investigators
-
Axel Franz, MD · University Hospital Tuebingen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Week
- Max Age
- 2 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2017-10-31
- Completion
- 2017-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Could Docosahexaenoic Acid (DHA), Contained in Breast Milk and Artificial Baby Milks, Protect Infants and Children From COVID-19 and Make Them Less Prone to COVID-19-related Severe Illness Than Adults?
NCT05075031 ·Status: UNKNOWN
-
Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain Development
NCT00332124 ·Status: COMPLETED ·Phase: PHASE1
-
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
NCT01601847 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Intensive Dietary Intervention in Children With Birth Weight Between 1500 and 2000 g
NCT02833818 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Human Milk Fortifiers in Preterm Infants
NCT02307760 ·Status: COMPLETED ·Phase: NA
-
Half-life of Plasma Phytosterols in Preterm Infants on Parenteral Nutrition
NCT02758834 ·Status: COMPLETED
-
Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs)
NCT06212427 ·Status: RECRUITING ·Phase: NA
-
The Effect of a New Infant Formula on Growth and Cognition in Healthy Term Infants
NCT04508257 ·Status: UNKNOWN ·Phase: NA
-
Vitamin E for Extremely Preterm Infants
NCT01193270 ·Status: COMPLETED ·Phase: PHASE1
-
Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants
NCT02372136 ·Status: COMPLETED ·Phase: NA
-
Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants
NCT02632266 ·Status: COMPLETED ·Phase: PHASE4
-
Feeding Bovine Colostrum to Preterm Infants
NCT02054091 ·Status: COMPLETED ·Phase: NA
-
Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies
NCT01674478 ·Status: COMPLETED ·Phase: PHASE2
-
Early Provision of Enteral Microlipid and Fish Oil to Infants With Enterostomy
NCT01306838 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Use of a Liquid Supplement Containing 2 Human Milk Oligosaccharides (HMOs) in Preterm Infants
NCT03607942 ·Status: COMPLETED ·Phase: NA
-
Effect of Formula on Infant Behavior
NCT02746016 ·Status: COMPLETED ·Phase: NA
-
Early Nutrition and Neurological Development of Very Preterm Infants
NCT01486173 ·Status: UNKNOWN
-
Medically-Graded Honey Supplementation Formula To Preterm Infants
NCT02679183 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effectiveness of Multicomponent Lipid Emulsion in Preterm Infants Requiring Parenteral Nutrition
NCT02663453 ·Status: COMPLETED ·Phase: PHASE3
-
Promotion of Thickened Feeds to Manage Newborns With Feeding Difficulties
NCT00859092 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Enteral Olive Oil Supplement On Weight Gain and Development of Some Complications in Preterm
NCT05815849 ·Status: COMPLETED ·Phase: NA
-
Effects of Parenteral Nutrition With Different Lipid Emulsions in Preterm Infants
NCT01683162 ·Status: UNKNOWN ·Phase: PHASE4
-
Dose Comparison of Amino Acids on Growth in Premature Neonates
NCT00120926 ·Status: COMPLETED ·Phase: PHASE3
-
Bifidobacterium Supplementation for Very Low Birth Weight Infants
NCT01375309 ·Status: COMPLETED ·Phase: NA
-
Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula
NCT04934397 ·Status: TERMINATED ·Phase: NA